Psoriasis, lichen planus, and disorders of keratinization: unapproved treatments or indications (Q33878550)

29 July 2017

1 reference

title

Psoriasis, lichen planus, and disorders of keratinization: unapproved treatments or indications (English)

1 reference

29 July 2017

1 reference

Capella GL

1

1 reference

29 July 2017

Finzi AF

series ordinal

2

1 reference

29 July 2017

publication date

1 March 2000

1 reference

29 July 2017

published in

Clinics in Dermatology

1 reference

29 July 2017

volume

18

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

159-169

1 reference

Off-label dermatologic therapies. Usage, risks, and mechanisms

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

The impossible in medicine

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Treatment of psoriatic arthropathy with either azathioprine or methotrexate.

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Psoriasis and occlusive vascular disease

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Mycophenolic acid for psoriasis. A review of pharmacology, long-term efficacy, and safety

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Psoriasis with Arthritis: Chemotherapy with Cyclophosphamide, Nitrogen Mustard and 6-Mercaptopurine

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Antipsoriatic effects of zidovudine in human immunodeficiency virus-associated psoriasis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Treatment of HIV-induced retinoid-resistant psoriasis with zidovudine

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Zidovudine for the treatment of HIV-negative patients with psoriasis: a pilot study.

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Topical methotrexate therapy for psoriasis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Topical 6-Aminonicotinamide Plus Oral Niacinamide Therapy for Psoriasis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Use of rifampin with penicillin and erythromycin in the treatment of psoriasis. Preliminary report

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Pristinamycin as alternative therapy of generalized pustular psoriasis during pregnancy

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Clearance of recalcitrant psoriasis after tonsillectomy

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Psoriasis and vitamin D3. A review of our experience

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Effects of Systemic Treatment with Liarozole on Cutaneous Inflammation, Epidermal Proliferation and Differentiation in Extensive Plaque Psoriasis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Inhibition of the metabolism of endogenous retinoic acid as treatment for severe psoriasis: an open study with oral liarozole.

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Exacerbation of psoriasis by the hypolipidemic agent, gemfibrozil

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

The effect of triamcinolone on psoriatic arthritis–A two year study

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Hormonal treatment of impetigo herpetiformis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Treatment of psoriasis with bromocriptin

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Propylthiouracil in psoriasis: results of an open trial

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Methimazole (2-mercapto 1-methyl imidazole) in psoriasis--results of an open trial

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Sulphasalazine in psoriatic arthritis: a double-blind placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Sulfasalazine improves psoriasis. A double-blind analysis.

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Desensitization of patients with inflammatory bowel disease to sulfasalazine

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

A double-blind evaluation of topical capsaicin in pruritic psoriasis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

A double-blind trial of clomocycline in the treatment of persistent palmoplantar pustulosis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Antimitotic Action of Griseofulvin does not Involve Disruption of Microtubules

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Successful treatment of generalized pustular psoriasis with clofazimine

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

The effect of dietary fish oil supplementation on psoriasis. Improvement in a patient with pustular psoriasis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Topical fish oil in psoriasis--a controlled and blind study

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Benoxaprofen improves psoriasis. A double-blind study

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

A dimethoxynaphthalene derivative (RS-43179 gel) compared with 0.025% fluocinolone acetonide gel in the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Intralesional cyclosporine for psoriasis. Relationship of dose, tissue levels, and efficacy

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Clearing of psoriasis by a novel immunosuppressive macrolide

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Immunointervention in psoriasis with anti-CD4 antibodies

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Recent advances in the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Systemic TNF administration in psoriatic patients: a promising therapeutic modality for severe psoriasis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

6-Methylangelicins: new monofunctional photochemotherapeutic agents for psoriasis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Photochemotherapy using pyridopsoralens

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Commercial Tanning Bed Treatment Is an Effective Psoriasis Treatment: Results from an Uncontrolled Clinical Trial

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Systemic therapy with fumaric acid derivates: new possibilities in the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Cimetidine and Psoriasis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

An open prospective clinical trial with systemic ranitidine in the treatment of psoriasis.

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Using aromatherapy in the management of psoriasis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Physical Occlusion Controlling Epidermal Mitosis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Peritoneal Dialysis for Psoriasis: A Controlled Study

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Water bath hyperthermia is a simple therapy for psoriasis and also stimulates skin tanning in response to sunlight

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Effects of Cascade Apheresis in Patients with Psoriasis and Psoriatic Arthropathy

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Resistant psoriasis. Combined methoxsalen-anthralin therapy

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Combinations and comparisons

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Management of psoriasis with Aloe vera extract in a hydrophilic cream: a placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

“Personalised” drug therapy could be near

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Topical cyclosporin in oral lichen planus: a controlled, randomized, prospective trial.

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Treatment of severe lichen planus with cyclosporine

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Erosive and generalized lichen planus responsive to azathioprine

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Intermittent megadose corticosteroid therapy for generalized lichen planus

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Treatment of lichen planus with temarotene

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

The epidermis of chronic idiopathic lichen planus during topical treatment with the vitamin D3 analogue KH 1060

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Low-dose low-molecular-weight heparin (enoxaparin) is beneficial in lichen planus: a preliminary report

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Lichen planus esophagitis with secondary candidiasis: successful combination treatment with ketoconazole and a corticosteroid

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Histopathological evaluation of griseofulvin therapy in lichen planus. A double-blind controlled study

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Idiopathic lichen planus: treatment with metronidazole

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Erosive lichen planus: dramatic response to thalidomide

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Lichen planus: treatment of thirty cases with systemic and topical phenytoin

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Successful treatment of generalized lichen planus with recombinant interferon alfa-2b

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Indications and contraindications for the use of DMSO in clinical dermatology

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right/left comparative study

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

The clinical and histomorphological features of pityriasis rubra pilaris. A comparative analysis with psoriasis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Treatment of pityriasis rubra pilaris with azathioprine

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Treatment of classic pityriasis rubra pilaris

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Pityriasis Rubra Pilaris Responding to Aminonicotinamide

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Adult pityriasis rubra pilaris: a 10-year case series

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Pityriasis rubra pilaris

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Clinical screening for breast cancer

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Vitamin A and pityriasis rubra pilaris

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Topical treatment of pityriasis rubra pilaris with calcipotriol

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Brief clinical reports of two cases of pityriasis rubra pilaris

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Hypothyroidism and pityriasis rubra pilaris. Response to thyroid hormone

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Pityriasis Rubra Pilaris Responsive to Ascorbic Acid

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Keratosis follicularis. (Darier's disease). Response to simultaneous administration of vitamins A and E

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Topical cholesterol treatment of recessive X-linked ichthyosis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Topical cholesterol treatment of recessive X-linked ichthyosis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Topical Application of Tazarotene in the Treatment of Nonerythrodermic Lamellar Ichthyosis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Failure of cyclosporine in Netherton's syndrome

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Explorations of antimitotic agents in the treatment of a congenital disease, Ichthyosis Linearis Circumflexa

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Successful therapy of ichthyosis linearis circumflexa with PUVA

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Scabies norvegica. Treatment with methotrexate

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

Issues confronting medicine

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(99)00106-6

7 January 2021

10.1016/S0738-081X(99)00106-6

Identifiers

DOI

1 reference

29 July 2017

1 reference